Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
ABL and CRD are rare disorders due to mutations in the MTP and SARA2 genes, respectively.
|
17570373 |
2007 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Abetalipoproteinemia: two case reports and literature review.
|
18611256 |
2008 |
Abetalipoproteinemia
|
0.800 |
Biomarker
|
disease |
BEFREE |
We report here the use of a polymorphic CA dinucleotide repeat in intron 10, MTPIVS10, of the large subunit of the human MTP protein in the analysis of a pregnancy in a consanguineous family, in which abetalipoproteinaemia was suspected, although prenatal diagnosis was subsequently refused.
|
9467817 |
1997 |
Abetalipoproteinemia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
These findings suggest that genetic and non-genetic factors can modulate the clinical impact of mutant MTP in ABL patients.
|
10679949 |
2000 |
Abetalipoproteinemia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Ileal adenocarcinoma in a mild phenotype of abetalipoproteinemia.
|
12630961 |
2003 |
Abetalipoproteinemia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia.
|
8533758 |
1995 |
Abetalipoproteinemia
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Peripheral neuropathy in abetalipoproteinemia.
|
2991816 |
1985 |
Abetalipoproteinemia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
A 30-amino acid truncation of the microsomal triglyceride transfer protein large subunit disrupts its interaction with protein disulfide-isomerase and causes abetalipoproteinemia.
|
7782284 |
1995 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Characterization of mutations in MTP causing abetalipoproteinemia has revealed that the central α-helical and C-terminal β-sheet domains are important for protein disulfide isomerase binding and lipid transfer activity.
|
26224785 |
2015 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the gene encoding the 97-kDa subunit of a microsomal triglyceride transfer protein (MTP) cause ABL (Sharp, D., Blinderman, L., Combs, K. A., Klenzle, B., Ricci, B., Wager-Smith, K., Gil, C. M., Turck, C. W., Bouma, M. E., Rader, D. J., Aggerbeck, L. P., Gregg, R. E., Gordon, D. A., and Wetterau, J. R. (1993) Nature 365, 65-69; Shoulders, C. C., Brett, D. J., Bayliss, J. D., Narcisi, T. M., Jarmuz, A., Grantham, T. T., Leoni, P. R. D., Bhattacharya, S., Pease, R. J., Cullen, P. M., Levi, S., Byfield, P. G. H., Purkiss, P., and Scott, J.(1993) Hum.Mol.Genet.2, 2109-2116).
|
8071315 |
1994 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Our results demonstrated that ABL SH3 mutant T79Y markedly repressed the expression of BCR-ABL signaling pathways in IM-resistant cell lines KCL22 and K562/G01 as well as IM-sensitive cell line K562.
|
26321052 |
2015 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Identification of a novel mutation of MTP gene in a patient with abetalipoproteinemia.
|
21502686 |
2011 |
Abetalipoproteinemia
|
0.800 |
Biomarker
|
disease |
BEFREE |
Sanger sequencing of MTTP was performed for two unrelated consanguineous Tunisian families with two affected individuals each, presenting a more severe ABL phenotype than previously reported in the literature.
|
24139731 |
2014 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Using induced pluripotent stem cells (iPSCs) generated from an ABL patient homozygous for a missense mutation (MTTP<sup>R46G</sup>), we show that human hepatocytes and cardiomyocytes exhibit defects associated with ABL disease, including loss of apolipoprotein B (apoB) secretion and intracellular accumulation of lipids.
|
28514664 |
2017 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
LHGDN |
ABL results from mutations in the MTP gene; Ho-FHBL may be due to mutations in the APOB gene.
|
19056372 |
2009 |
Abetalipoproteinemia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
These results indicated that defects of the MTP gene are the proximal cause of ABL.
|
10946006 |
2000 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Molecular and functional analysis of two new MTTP gene mutations in an atypical case of abetalipoproteinemia.
|
22236406 |
2012 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Abetalipoproteinemia and homozygous hypobetalipoproteinemia are classical Mendelian autosomal recessive and co-dominant conditions, respectively, which are phenotypically similar and are usually caused by bi-allelic mutations in MTTP and APOB genes, respectively.
|
29540175 |
2018 |
Abetalipoproteinemia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Molecular and functional analysis of two new MTTP gene mutations in an atypical case of abetalipoproteinemia.
|
22236406 |
2012 |
Abetalipoproteinemia
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
We discovered a novel mutation in MTTP gene and we confirmed the diagnosis of abetalipoproteinemia in new Tunisian families.
|
23556456 |
2013 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Fluorescence in situ hybridization (FISH) analyses using BCR and ABL probes showed that in 20% of metaphases BCR and ABL signals were present on one chromosome 6 at 6p23, whilst in 80% of metaphases BCR and ABL signals were identified on both copies of chromosome 6.
|
7596189 |
1995 |
Abetalipoproteinemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Nevertheless, we found increased abundance of fecal Akkermansia from two adult ABL subjects with MTTP mutations compared to their heterozygous parents and within the range noted in six healthy control subjects.
|
31004524 |
2019 |
Abetalipoproteinemia
|
0.800 |
Biomarker
|
disease |
BEFREE |
ABL (ABL1) and ARG (ABL2) are highly homologous to each other in overall domain structure and amino-acid sequence, with the exception of their C termini.
|
28386107 |
2017 |
Abetalipoproteinemia
|
0.800 |
Biomarker
|
disease |
HPO |
|
|
|
Abetalipoproteinemia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
These studies point out that ABL is associated with the absence of both triglyceride and phospholipid transfer activities in MTP.
|
23475612 |
2013 |